Ms. Schroeder has served on the company’s board of directors, and she succeeds Glen Kashuba, who will continue to serve as an adviser to the company.
Ms. Schroeder has served as KCK Medtech’s managing director since 2016 and has held senior roles at other medical technology companies.
“I am excited to lead Cerapedics as we advance through the next phase of the company,” Ms. Schroeder said in an Oct. 10 press release. “We look forward to delivering improved bone repair outcomes for patients, doctors and payers with our innovative P-15 peptide technology that has demonstrated strong clinical performance in a randomized controlled study, and has demonstrated cost-effectiveness in cervical fusion.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
